18F-FDG PET/CT纹理分析或可对II期结直肠癌进行风险分层:发现性研究
这项多中心前瞻性观察研究纳入66例经活检证实的II期结直肠癌患者,术前接受18F-FDG PET/CT检查。分析显示,CT纹理像素平均强度<20.390(粗纹理尺度)和SUVmax≥25.560 g/mL与死亡风险升高相关,联合指标风险比达5.44,提示多参数PET/CT可能优于T分期进行预后分层。
要点
- CT纹理像素平均强度<20.390与死亡风险升高相关(HR 3.40)。
- SUVmax≥25.560 g/mL与死亡风险升高相关(HR 3.45)。
- 两项参数联合时死亡风险HR为5.44,优于T分期。
核心结论
- 多参数18F-FDG PET/CT可能为II期结直肠癌提供预后标志物,风险分层优于T分期。
研究设计与样本
- 多中心、前瞻性观察研究,纳入66例经活检证实的II期结直肠癌患者(41男25女,平均年龄69.1±10.3岁),术前接受18F-FDG PET/CT。
主要发现
- 随访期间49例存活,平均总生存期88.4±42.3个月。
- 单因素分析显示性别、年龄、肿瘤侧别、位置、体积及高危组织病理学指标均与生存无显著关联。
- T3与T4分期之间未见显著生存差异(p=0.748)。
- CT纹理像素平均强度<20.390(粗纹理尺度)者死亡风险升高,HR 3.40(1.36-8.49),p=0.005。
- SUVmax≥25.560 g/mL者死亡风险升高,HR 3.45(1.31-9.12),p=0.008;两参数联合时HR 5.44(1.75-16.91),p=0.001。
关键数值与推荐
- CT纹理像素平均强度<20.390(粗纹理尺度)与死亡风险升高相关。
- SUVmax≥25.560 g/mL与死亡风险升高相关。
- 上述参数经3折交叉验证仍显著,多因素Cox回归分析显示为独立预测因子。
临床怎么用
- 对于II期结直肠癌患者,术前18F-FDG PET/CT纹理分析可辅助识别高危复发/死亡风险人群,可能指导是否追加治疗。
局限性
- 本研究为初步发现性研究,样本量较小(66例),结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: It is challenging to identify which patients with Stage II colorectal cancer (T3N0M0 and T4N0M0) are at high risk of recurrence and might benefit from additional therapies. This preliminary study examines whether multiparametric [18F]FDG PET/CT is superior to T-stage in predicting overall survival in this patient group. MATERIALS AND METHODS: This multicentre, prospective observational study included 66 patients (41 male, 25 female, mean age 69.1 ± 10.3yrs) with biopsy-proven Stage II colorectal cancer who underwent [18F]FDG PET/CT prior to resection. Kaplan-Meier analysis was performed on PET and image texture parameters and clinico-histopathological markers to identify associations with survival. P-values were adjusted using the Benjamini-Hochberg procedure, and the most statistically significant radiomic parameters underwent 3-fold cross-validation. Multivariate Cox regression analysis was used to determine independence of prognostic markers. RESULTS: 49 patients survived the follow up period, with a mean overall survival of 88.4 (± 42.3 months). Univariate analysis showed no significant survival association with clinical variables such as patient sex (p = 0.295), age (p = 0.085), tumour side (p = 0.662), location (p = 0.848) or volume (p = 0.782), or high-risk histopathological metrics including low number lymph node sampling (p = 0.363), perineural, lymphovascular or extramural tumour invasion (p = 0.196), poor tumour differentiation (p = 0.372), and tumour perforation (p = 0.475). No significant survival difference was observed between T3 and T4-stages (p = 0.748). An increased mortality risk was observed for patients with a pixel mean intensity < 20.390 on CT texture (coarse texture scale), HR: 3.40 (1.36-8.49); p = 0.005, and where SUVmax ≥ 25.560 g/mL on [18F]FDG PET/CT, HR: 3.45 (1.31-9.12); p = 0.008. These parameters remained significant after 3-fold cross validation and were independent predictors of survival after Multivariate Cox regression analysis. A higher mortality risk was indicated when the parameters were combined (5 of 66 patients), hazard ratio: 5.44 (1.75-16.91); p = 0.001. CONCLUSION: Multiparametric [18F]FDG PET/CT can potentially provide prognostic markers for patients with stage II colorectal cancer with superior risk stratification compared to T-stage.
引用
- Rice L, Ganeshan B, Wan S, et al. Texture analysis of [18F]FDG PET/CT may stratify risk in stage II colorectal cancer - discovery findings. Eur J Nucl Med Mol Imaging. 2025. PMID: 41051536. doi:10.1007/s00259-025-07568-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。